Tempus AI makes IPO debut, valuing the precision medicine startup at $6 billion
After years of anticipation, AI-driven precision medicine startup Tempus AI is finally making its debut on the U.S. market. Backed by heavyweights like Google and SoftBank Group, Tempus AI has set the price of its initial public offering (IPO) at […]